New Hybrid COVID Strain XEC: An Overview
The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the Omicron family. While still closely related to prior strains, this one carry unique transmission traits and is under rigorous observation by health officials.
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
For those wanting the home test kit, free rapid antigen tests will continue to be available through local public health units ...
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older The KP.2 adaptation is based on FDA ...
While XEC is spreading, experts emphasise that its arrival doesn’t signal a drastic shift in the COVID landscape ... severe disease compared to other Omicron subvariants. However, with colder ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...
1 sublineages, including KP.2, KP.3 and LB.1, compared with the companies’ Omicron XBB.1.5 adapted COVID-19 vaccine.3 The COVID-19 vaccines by Pfizer and BioNTech are based on BioNTech’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback